FIELD: medicine.
SUBSTANCE: invention refers to ophthalmology, and aims at treating dystrophic ophthalmopathies. Gel "Lamifaren" is prescribed in an oral dose 20 g once a day, 30 minutes before a meal. Additionally, "Selzinc" is prescribed in an oral dose 1 tablet; 30 minutes later, lateral galvanisation follows. Two anode electrodes are glued within the orbits, while the third cathode electrode - within the forehead on the midline, closer to the bridge of nose. Duration of galvanisation is 10 minutes, at current strength 1 mA. Number of procedures is 10. Then during three months, 20 g of gel "Lamifaren" and one tablet of "Selzinc" are administered daily. Said therapy is carried out every 2 months.
EFFECT: method allows improving the level of oxidation-reduction reactions, stimulating metabolic processes and stabilising cell membranes.
3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
SURGICAL METHOD FOR TREATING NONCOMPENSATED OPEN ANGLE GLAUCOMA | 2006 |
|
RU2317051C1 |
METHOD FOR PREPARING PATIENTS BEFORE OPERATION TO SURGICAL TREATMENT OF CATARACT COMPLICATED WITH GLAUCOMA | 2006 |
|
RU2314069C1 |
METHOD OF TREATING CATARACT IN PATIENTS WITH PSEUDOEXFOLIATION SYNDROME | 2013 |
|
RU2515550C1 |
METHOD FOR DETERMINING INDICATIONS TO SURGICAL MANAGEMENT OF CATARACT AND OPEN-ANGLE GLAUCOMA | 2009 |
|
RU2413482C1 |
MULTIMODALITY THERAPY OF PRIMARY OPEN-ANGLE GLAUCOMA AND CATARACT | 2008 |
|
RU2380072C1 |
METHOD FOR REMOVING IRIDAL STRANGULATION WITH POSTERIOR-CHAMBER IOL | 2003 |
|
RU2257183C2 |
METHOD OF NONPENETRATING DEEP SCLERECTOMY | 2015 |
|
RU2595045C1 |
METHOD OF TREATING HELCOMA | 2008 |
|
RU2381018C1 |
METHOD FOR PREVENTING POSTOPERATIVE COMPLICATIONS IN IMPLANTING ARTIFICIAL EYE LENS | 1997 |
|
RU2164395C2 |
METHOD FOR DETERMINING INDICATIONS FOR SURGICALLY TREATING CATARACT AND OPEN ANGEL GLAUCOMA AGGRAVATED WITH PSEUDOEXFOLIATIVE SYNDROME IN HIGH-LEVEL VISION FUNCTION CASES | 2006 |
|
RU2306840C1 |
Authors
Dates
2010-05-20—Published
2008-10-16—Filed